ArticleMed (New York, N.Y.)2021

A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis.

Naoto Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.